Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment

G. Venkatraman, M. G. K. Benesch, X. Tang, J. Dewald, T. P. W. McMullen, D. N. Brindley
  • The FASEB Journal, November 2014, Federation of American Societies For Experimental Biology (FASEB)
  • DOI: 10.1096/fj.14-262659
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr David N Brindley